Home / Markets / News / Natco Pharma slips 8% on weak Q4 results; stock hits new low

Natco Pharma slips 8% on weak Q4 results; stock hits new low

The company's consolidated net profit more-than-halved at Rs 120 crore in March quarter against Rs 300 crore in the year-ago quarter.

Premium

Growth in the US market was the reason for the overall revenue rise of many companies

2 min read Last Updated : May 28 2019 | 11:00 AM IST

Shares of Natco Pharma hit a new low of Rs 482, down 8 per cent on the BSE in early morning trade, after the company reported a decline in net profit for the second consecutive quarter, due to lower revenue growth.

The pharma company’s consolidated net profit more-than-halved at Rs 120 crore in March 2019 quarter (Q4FY19). It had posted a profit of Rs 300 crore in the year-ago quarter.

Operational revenue declined 41 per cent to Rs 456 crore against Rs 768 crore in the corresponding quarter of previous fiscal. Ebitda (earnings before interest, taxation, depreciation and

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in